Vir Biotechnology (VIR) PT Raised to $61 at Goldman Sachs, Following Earnings

February 26, 2021 3:28 PM EST
Get Alerts VIR Hot Sheet
Price: $46.38 +2.98%

Rating Summary:
    6 Buy, 0 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Goldman Sachs analyst Paul Choi raised the price target on Vir Biotechnology (NASDAQ: VIR) to $61.00 (from $54.00) while maintaining a Buy rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

Goldman Sachs, Earnings